(R)-Crinecerfont | CAS 2649012-21-3 - Request Quote
(R)-Crinecerfont
| SZ CAT No: | SZ-C271002 |
| CAS No | 2649012-21-3 |
| Mol.F. | C27H28ClFN2OS |
| Mol.Wt. | 483 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
(R)-Crinecerfont is chemically (R)-4-(2-chloro-4-methoxy-5-methylphenyl)-N-(2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl)-5-methyl-N-(prop-2-yn-1-yl)thiazol-2-amine. It is also known as Crinecerfont Enantiomer. (R)-Crinecerfont is supplied with detailed characterization data compliant with regulatory guideline. (R)-Crinecerfont can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Crinecerfont.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2649012-21-3
Purchase 2649012-21-3
Order 2649012-21-3
Enquire 2649012-21-3
price of 2649012-21-3
2649012-21-3 Supplier
2649012-21-3 Manufacturer
2649012-21-3 Exporter
buy high quality (R)-Crinecerfont
Purchase (R)-Crinecerfont
(R)-Crinecerfont suppliers
(R)-Crinecerfont manufacturers
(R)-Crinecerfont price
Order (R)-Crinecerfont
Enquire (R)-Crinecerfont
(R)-Crinecerfont cost
(R)-Crinecerfont Supplier
(R)-Crinecerfont Distributor
(R)-Crinecerfont for Method Validation
Crinecerfont Reference Standard
(R)-Crinecerfont for ANDA Filing
(R)-Crinecerfont for Forced Degradation Studies
(R)-Crinecerfont Identification Standards
(R)-Crinecerfont for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.